China is investing heavily in cutting-edge genetic experiments. It’s part of their quest to become a biotech superpower.
On today’s Big Take Asia Podcast, host K. Oanh Ha, Bloomberg’s Karoline Kan and Oxford University geneticist Andy Greenfield discuss China’s pharmaceutical ambitions and the loose regulatory environment that allows the animal testing industry to thrive.
Read more: China Pushes Boundaries With Animal Testing to Win Global Biotech Race

The Sixth Bureau Episode 5: One Way In, One Way Out
33:01

War in Iran Is Exposing Oil Risks Across Asia
17:55

Former Secretary of State on the Two Keys to Ending War in Iran
37:34